CD40LG and fungal infectious disease: Beyond the anti-CD40 IgG4/anti-CD40L PAS-Fab combination therapy, all animals received mycophenolate mofetil as a generally immunosuppressive drug, which is known to increase the risk of fungal infections [71,72,73].